Antiarthritic agents
Psoriatic Arthritis Remains Difficult to Treat: Study
Researchers at Hospital Clinic Barcelona have revealed new insights into the challenges of treating psoriatic arthritis, with nearly one-fourth of patients remaining active despite multiple treatments. The study, published in the journal Diagnostics, found that difficult-to-treat (D2T) psoriatic arthritis is associated with disease duration, comorbidities, activity, HLA-B27, and combined therapies.